Perrigo: As of June 25, the proportion of repurchased shares reached 1.11%.

Pailin Biotechnology announced that the company passed a proposal to repurchase shares through concentrated bidding on April 27, 2026. It plans to repurchase A shares with a total amount of 200 million to 300 million yuan using its own funds or self-raised funds, with a repurchase price not exceeding 19.50 yuan per share and a term of 12 months. As of June 25, the company had repurchased 10.5518 million shares, accounting for 1.11% of the total share capital, with a highest transaction price of 12.94 yuan per share, a lowest of 9.00 yuan per share, and a total transaction amount of 1.16 billion yuan. The company will continue to implement the repurchase plan as scheduled and disclose information promptly.